Table 2.
Study (authors-year) | Representativeness of the exposed cohort | Selection of the nonexposed cohort | Ascertainment of exposure | Demonstration that outcome of interest was not present at the start of the study | Comparability of cohorts on the basis of the design or analysis | Assessment of outcome | Was it followed up long enough for outcomes to occur? | Adequacy of follow-up of cohorts | Total score |
---|---|---|---|---|---|---|---|---|---|
Pretreatment | |||||||||
Song BG (2018) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Paik N (2018) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Chang KC (2018) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Kim JH (2018) | ★ | ★ | ★ | — | ★ | ★ | ★ | ★ | 7 |
Nishikawa H (2017) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Ji FP (2017) | ★ | ★ | ★ | — | — | ★ | ★ | ★ | 6 |
Kim JH (2016) | ★ | ★ | ★ | — | — | ★ | ★ | ★ | 6 |
Lee K (2016) | ★ | ★ | ★ | — | — | ★ | ★ | ★ | 6 |
Wu CK (2016) | ★ | ★ | ★ | — | — | ★ | ★ | ★ | 6 |
Ng KJ (2016) | ★ | ★ | ★ | — | ★ | ★ | ★ | ★ | 7 |
Hann HW (2015) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Posttreatment | |||||||||
Ji FP (2017) | ★ | ★ | ★ | — | — | ★ | ★ | ★ | 6 |
Wu CK (2016) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Chen TM (non-SVR) (2016) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Chen TM (SVR) (2016) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
Yu ML (2006) | ★ | ★ | ★ | — | ★★ | ★ | ★ | ★ | 8 |
A study can be awarded a maximum of two stars for comparability of cohorts on the basis of the design or analysis. A maximum of one star can be given for other seven items.